April 5, 2022
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for the Distribution of CannEpil and CogniCann in the EU and UK
MGC Pharmaceuticals Ltd, a European based bio-pharma company specialising in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare , a part of UK health care group, Sciensus, for the distribution of CannEpil and CogniCann in key European territories and the UK